Journal of Therapeutic Biotechnology (JTB)

Journal, Therapeutic, Biotechnolgy, JTB, Biologics, industry, New Drug development

Call for editors, authors and sponsors...
Call for articles and reviews...
Call for page layout, logo, Chem Bio Draw, artistic, photographic and technical help...
Call for suggestions/improvements...
Start date Journal of Therapeutic Biotechnology (JTB) Q2, 2010?

Table des matières

LES AUTEURS

Krishan Maggon

Consultant Pharmaceutical Biotechnology R&D & Advisor

Geneva, Switzerland & New York, USA

Salim Djelouat

Professor Medical Analyses and Medical bacteriology / Scientific Author / knolAuteur

Gust MEES

Formateur andragogique/pédagogique TIC (ICT Course Instructor), Luxembourg

Patrick Lahaye

Infographiste 2D & 3D, Webmaster, Belgique

Knol Publishing Guild (KPG)

Serving the publishing aspirations of Knol writers, Planet Earth

Main link

We need many more knol authors in the Team to start the Journal before the end of this year as a moderated collection.

Introduction

Please write here a small introduction, ideas and why JTB...

Commercial Use:

The name, current and future logo and content of Journal of Therapeutic Biotechnology (JTB) is protected worldwide under US Copyright Law, Bern Convention and Universal Copyright Convention. For fair use (<10 words), full citation of the source including a direct hyperlink must be included. Use of all or any part of this knol for commercial purposes or supporting any type of commercial activity requires a formal written license (not email) which can be requested directly from the author.

---> Please respect the IPR (Intellectual Propriety Rights) of author's. <---

False Claims

All claims by any web based site as Publisher of this journal are false and misleading. In spite of keen interest expressed by several e-book publisher, the author has not authorized anyone to publish, sell or market this journal.

Questions for discussion/debate

Publish as a collection or Book form?

Nomination of Editors

Function and contribution of Editors

Article submission
Sharing of page views, adsense revenue, sponsorships, coauthors etc
Responsibilities
Review process
Publication
Archives
Keyword search
Logo or Home Page design

JTB Editors (Proposed and not yet contacted)

Editor in Chief

Prof
University

USA

Editor USA or North America

Tbd

Chief Editor Europe
Prof Salim Djelouat

Editor India

Prof
University of Delhi

Editor Asia Japan/China

Editor Middle East

Editor Africa

Editor Latin America

JTB Editorial Advisory Board

TBD

( University, UK)

Director from Industry

Director Biotech company:

JTB Web Designers/Experts Team:

The first multimedia platform journal for publication with integrated or soon to be integrated articles embedded with Ability to Integrate/Embed

Images	Document
Picasa Web Albums slideshow	Presentation
Video	Spreadsheet
Google Calendar	Spreadsheet Form

Acknowledgements

Thanks are due to Mr. Jean-Antoine de Mandato (PDP, Geneva) for providing office facilities and administrative support.

The email and website of the journal will be created ASAP. Do we need a web Page or stay in knol?.

How to set up 5-10 gmail accounts for the journal?

If interested to join as sponsor, editor or contribute a paper as author, please add your comments at the knol?

Technical help for artistic, technical input, page layout, logo, web design, web hosting, site management suggestions invited from the knol community.

Our Model Knol Journal

The start of the PLoS Current as a moderated collection gives us the model to follow for JTB

PLoS Currents/Influenza: http://knol.google.com/k/plos/plos-currents-influenza/28qm4w0q65e4w/1#

Examples of Journals with attractive Page Layouts:

JAMA, the Journal of the American Medical Association:	http://jama.ama-assn.org/
Canadian Medical Association Journal:	http://www.cmaj.ca/
Nature Biotechnology:	http://www.nature.com/nbt/index.html
Journal of Biotechnology	Elsevier
Elsevier	Elsevier description
Biotechnology Journal:	http://www3.interscience.wiley.com/journal/110544531/home

Sponsors, donation, funding Enquiries for Journal of Therapeutic Biotechnology (JTB)

Please contact the Editor if interested as a sponsor of JBT.

Call for Sponsors:

To all funding agencies, foundations and publishers for initial funding and start up costs for a peer reviewed online biotechnology journal.

Benefits for Sponsors

Advertise your biotech drug brand as lecture slides, popular story, voice recording, pictures, musical, film or video? High visibility, high Page view

Display Rates
tbd

Journal of Therapeutic Biotechnology Editors :

Must be MD or PhD with minimum 5-10 years prior experience with clinical testing and therapeutic use of biotechnology derived medicines and tenured track faculty position. Academic, legal, regulatory, financial, venture capital, investors and industrial experts with experience in other aspects of biotechnology like production, scaleup, GMP, manufacture, QA, regulatory and marketing are welcome. Expert panel of editors from different regions of the world is required. A short CV with list of publications and email is required for nomination to the editorial board and will be posted in the journal. The editorial panel (>15) will elect Chairman, 3-5 regional Vice Chairs and additional 5-8 editors of the editorial advisory board. All editors must contribute at least 1 hour per working day to the journal and 1 article per year.

Authors: Why Publish in Journal of Therapeutic Biotechnology

No page charges(Save 5000-10,000 $)No extra charges for colored Figures, photographs, artwork, audio or video input (saves 3000 $)

Fast track status and priority review

Fast peer reviewed publication by 3rd week of submission.

A five star evaluation system

Round the clock editorial review due to geographic location of editors.

Open access to all articles

Greater visibility and exposure

Daily Page View, Comments and reviews measures Impact of your article and feedback from your audience

Priority publications supports your patents, brands and IPR

Author Declaration:

The declaration must be signed by all authors:

That the submission is a new creative contribution.
It has not been previously submitted to any other biomedical journal.
It has not been rejected by other journals.
The work is original and is not copied, old recycled or plagiarised material.
All rules, regulations and guidelines were adhered to for the conduct of the studies.
Integrity of the data was insured by the pricipal investigator.
Conflict of interest statement.
Contributions of all listed authors must be specified.

Citing of self references will be limited to 20% of total 25-35 (50 for review articles) references cited.
Proof of concept should be provided in simple and clear terms.

All submitted papers will be rated within 1-2 weeks from 1* to 5* and papers with 3* or more will be published in the journal. All articles rated 3* or more will be reviewed by 2-3 editors. All other papers can be published as knol.

Authors will have the right to challenge the star rating and can ask for evaluation by the Chairman or Vice Chair. Their opinion will be final.

Authors Resources

Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication.

http://www.icmje.org/

Mulford Health Science Library Instructions to authors in the health sciences

http://mulford.meduohio.edu/instr/itoaC.php

Ethical Guidelines

World Medical Assembly Declaration of Helsinki

http://www.wma.net/e/policy/b3.htm

Good Clinical Practise GCP

http://www.fda.gov/oc/gcp/

http://www.ich.org/LOB/media/MEDIA482.pdf

Clinical Trials submission

All clinical trials must comply with all applicable national and international laws, rules, regulations and guidelines. Sponsors and investigators must strive to attain highest scientific, technical, analytical, medical and ethical standards.
All papers dealing with clinical trials must be accompanied by: